Risperdal and Invega

Photo Credit

Weldon Stanford

- Author, Drug Guardians

Several shipments of Risperdal, Risperdal Consta, and Invega, powerful anti-spychotic drugs manufactured by pharmaceutical giant Johnson & Johnson, were recalled in 2011 and 2013 over contamination concerns. The drugs have also been linked to gynecomastia, which causes male patients to develop breasts, and tardive dyskenesia, which causes involuntary facial movement.